566 related articles for article (PubMed ID: 30949182)
1. Shaping of CD56
Ni M; Wang L; Yang M; Neuber B; Sellner L; Hückelhoven-Krauss A; Schubert ML; Luft T; Hegenbart U; Schönland S; Wuchter P; Chen BA; Eckstein V; Krüger W; Yerushalmi R; Beider K; Nagler A; Müller-Tidow C; Dreger P; Schmitt M; Schmitt A
Front Immunol; 2019; 10():547. PubMed ID: 30949182
[TBL] [Abstract][Full Text] [Related]
2. Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects.
Wang L; Ni M; Hückelhoven-Krauss A; Sellner L; Hoffmann JM; Neuber B; Luft T; Hegenbart U; Schönland S; Kleist C; Sill M; Chen BA; Wuchter P; Eckstein V; Krüger W; Hilgendorf I; Yerushalmi R; Nagler A; Müller-Tidow C; Ho AD; Dreger P; Schmitt M; Schmitt A
Front Immunol; 2018; 9():2207. PubMed ID: 30349527
[TBL] [Abstract][Full Text] [Related]
3. An early increase of CD56
Iniesta P; Revilla N; Chen-Liang TH; Hurtado AM; Vicente V; Heras I; Jerez A; Lozano ML
Transfusion; 2018 Dec; 58(12):2924-2932. PubMed ID: 30260547
[TBL] [Abstract][Full Text] [Related]
4. Modulation of lymphocyte subpopulations by extracorporeal photopheresis in patients with acute graft-versus-host disease or graft rejection.
Lorenz K; Rommel K; Mani J; Jin N; Hilgendorf I; Ho AD; Freund M; Schmitt M; Schmitt A
Leuk Lymphoma; 2015 Mar; 56(3):671-5. PubMed ID: 24913503
[TBL] [Abstract][Full Text] [Related]
5. Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease.
Oarbeascoa G; Lozano ML; Guerra LM; Amunarriz C; Saavedra CA; Garcia-Gala JM; Viejo A; Revilla N; Acosta Fleitas C; Arroyo JL; Martinez Revuelta E; Galego A; Hernandez-Maraver D; Kwon M; Diez-Martin JL; Pascual C;
Biol Blood Marrow Transplant; 2020 Apr; 26(4):651-658. PubMed ID: 31917270
[TBL] [Abstract][Full Text] [Related]
6. Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid-resistant acute and chronic graft-vs-host disease after allogenic hematopoietic stem cell transplant.
Amat P; López-Corral L; Goterris R; Pérez A; López O; Heras I; Arbona C; Viguria MC; Hernández-Boluda JC; Martínez-Ruiz F; Martínez A; Solano C
J Clin Apher; 2021 Oct; 36(5):697-710. PubMed ID: 34185332
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease.
Belizaire R; Kim HT; Poryanda SJ; Mirkovic NV; Hipolito E; Savage WJ; Reynolds CG; Fields MJ; Whangbo J; Kubo T; Nikiforow S; Alyea EP; Armand P; Cutler CS; Ho VT; Blazar BR; Antin JH; Ritz J; Soiffer RJ; Koreth J
Blood Adv; 2019 Apr; 3(7):969-979. PubMed ID: 30936057
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report.
Berger M; Pessolano R; Albiani R; Asaftei S; Barat V; Carraro F; Biasin E; Madon E; Fagioli F
J Pediatr Hematol Oncol; 2007 Oct; 29(10):678-87. PubMed ID: 17921848
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo.
Malagola M; Cancelli V; Skert C; Leali PF; Ferrari E; Tiburzi A; Sala ML; Donnini I; Chiusolo P; Mussetti A; Battista M; Turra A; Cattina F; Rambaldi B; Schieppati F; Polverelli N; Bernardi S; Perucca S; Marini M; Laszlo D; Savignano C; Patriarca F; Corradini P; Piccirillo N; Sica S; Bosi A; Russo D
Transplantation; 2016 Dec; 100(12):e147-e155. PubMed ID: 27861297
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photophoresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
[TBL] [Abstract][Full Text] [Related]
12. Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Ussowicz M; Musiał J; Mielcarek M; Tomaszewska A; Nasiłowska-Adamska B; Kałwak K; Gorczyńska E; Mariańska B; Chybicka A
Transplant Proc; 2013 Nov; 45(9):3375-80. PubMed ID: 24182819
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study.
Berger M; Albiani R; Sini B; Fagioli F
Transfusion; 2015 Apr; 55(4):736-47. PubMed ID: 25355659
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: results of treatment with the COBE Spectra System.
Hautmann AH; Wolff D; Hahn J; Edinger M; Schirmer N; Ammer J; Holler B; Landfried K; Hautmann MG; Ahrens N; Ugocsai P; Andreesen R; Holler E
Bone Marrow Transplant; 2013 Mar; 48(3):439-45. PubMed ID: 22922407
[TBL] [Abstract][Full Text] [Related]
15. Early Cytomegalovirus Reactivation and Expansion of CD56
Jang JE; Hwang DY; Chung H; Kim SJ; Eom JI; Jeung HK; Song J; Kim JS; Cheong JW; Min YH
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2070-2078. PubMed ID: 31212079
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience.
Calore E; Marson P; Pillon M; Tumino M; Tison T; Mainardi C; De Silvestro G; Rossin S; Franceschetto G; Carraro E; Pescarin M; Varotto S; Destro R; Gazzola MV; Basso G; Messina C
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1963-72. PubMed ID: 26183078
[TBL] [Abstract][Full Text] [Related]
17. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
Perfetti P; Carlier P; Strada P; Gualandi F; Occhini D; Van Lint MT; Ibatici A; Lamparelli T; Bruno B; Raiola AM; Dominietto A; Di Grazia C; Bregante S; Zia S; Ferrari GM; Stura P; Pogliani E; Bacigalupo A
Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of extracorporeal photopheresis in pediatric patients with graft-versus-host disease after hematopoietic stem cell transplantation.
Winther-Jørgensen S; Nygaard M; Heilmann C; Ifversen M; Sørensen K; Müller K; Masmas T
Pediatr Transplant; 2019 Jun; 23(4):e13416. PubMed ID: 30973668
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal photopheresis as an immunomodulatory agent: Haematocrit-dependent effects on natural killer cells.
Becherucci V; Allegro E; Brugnolo F; Piccini L; Gori V; Bisin S; Bindi B; Ceccantini R; Pavan P; Cunial V; Gentile F; Ermini S; Bambi F
J Clin Apher; 2017 Aug; 32(4):257-265. PubMed ID: 27476149
[TBL] [Abstract][Full Text] [Related]
20. Response to extracorporeal photopheresis therapy of patients with steroid-refractory/-resistant GvHD is associated with up-regulation of Th22 cells and Tfh cells.
Ni M; Wang L; Ding Y; Gong W; Wang S; Neuber B; Schubert ML; Sauer T; Hückelhoven-Krauss A; Luft T; Hegenbart U; Schönland S; Eckstein V; Wang J; Krüger W; Müller-Tidow C; Dreger P; Schmitt M; Schmitt A
Cytotherapy; 2022 Mar; 24(3):311-319. PubMed ID: 34711501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
